China has made major gains in public health, improving medical access and life expectancy. Yet a rapidly growing problem is emerging among younger people: chronic and critical illnesses once associated mainly with middle age and older populations are increasingly affecting children, adolescents and young adults. Diabetes, cardiovascular disease, cancers and respiratory illness are reshaping the country’s health profile and creating new social, economic and insurance challenges.
Warning Signs Are Appearing Earlier
Marc Burban pointed to childhood obesity as one worrying trend. A Chinese study found that people who were obese in early adulthood had a 58% higher risk of cardiovascular disease later in life than those with a healthy BMI. A 2024 national survey found Type 2 diabetes in 1.77 per 1,000 schoolchildren aged 3 to 18, up from 0.56 in 2010. Pre-diabetic indicators were more widespread: 28.46 per 1,000 had impaired glucose tolerance and 53.74 per 1,000 had impaired fasting glucose, both significantly higher than in 2010.
A Widening Protection Gap
Claims data filed by 60 Chinese insurers in 2022 showed that the number of younger people making critical-illness claims was increasing. China Life reported that the detection rate of critical illness among insured people aged 25-45 rose from 6.3 per 10,000 in 2013 to 12 per 10,000 in 2022. The number of critical illnesses covered by insurance in China has expanded from around a dozen three decades ago to more than 100. In 2023 claims reports, malignant tumours ranked first, followed by acute myocardial infarction, cerebral infarction and end-stage renal disease.
A Global Cancer Observatory report cited in the article recorded more than 850,000 new cancer cases and more than 300,000 cancer deaths among Chinese adults aged 20-49 in 2022, compared with about 320,000 new cases and 120,000 deaths in 2000.
Lifestyle and Structural Drivers
The rise is not explained by ageing or genetics alone. Urbanisation, sedentary work, high stress, air pollution and poor diet all contribute to chronic disease. The article also notes emerging research on microplastics as a possible carcinogenic risk. Work stress and low activity compound the problem: more than 75% of urban workers report job-related fatigue, while a study of 2,222 Chinese adults found only 56.8% achieved the recommended 150 minutes of physical activity per week. Another study found inactivity among adults aged 18-34 rose from 17.9% in 2010 to 22.3% in 2018.
Low health literacy and social stigma around illnesses such as cancer can delay diagnosis and treatment. A 2023 study in Hunan found that these factors contributed to late recognition of cancer symptoms, especially among younger adults. Inadequate screening, weak prevention routines and insufficient insurance protection can leave younger people financially unprepared for serious illness.
Insurers Move from Payers to Health Partners
For insurers, the trend is both a risk and a market opportunity. The article cites estimated treatment costs of CNY220,000-800,000 for cancer and CNY100,000-300,000 for acute myocardial infarction and coronary artery bypass grafting. Medical bills are only part of the burden: patients may also face rehabilitation, nursing and living costs as well as lost income. Insurers are responding with products that prioritise early access, affordability and digital convenience, including China Life’s ZhenAiWuYou, Huatai Life’s ZhenXiangBao and digital-first health products from Ping An.
Innovation Must Remain Sustainable
Product innovation should broaden relevant health coverage while keeping premiums affordable and sustainable. Insurers need to monitor healthcare trends, strengthen research, and take a more active role in risk and health management rather than acting only as passive benefit payers. The stakes extend beyond insurance: rising illness among younger people can reduce workforce participation and increase healthcare expenditure, making prevention and better risk management important to China’s long-term economic health.
COLACO.TECH